Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy
Phase of Trial: Phase III
Latest Information Update: 14 Jul 2017
At a glance
- Drugs Alendronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms BILANZ
- 23 May 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2011-000290-31).
- 23 May 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 21 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.